Clinicians should maintain a high index of suspicion for parathyroid carcinoma when evaluating patients with primary hyperparathyroidism, especially if there are palpable masses or atypical imaging findings alongside elevated parathyroid hormone (PTH) and hypercalcemia levels. The gene discussed is PTH; the disease is Hypercalcemia.